New Drugs and Devices for HF Therapy

Published: 31 July 2020

  • Views:

    Views Icon 57

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This session was part of the 1st e-SPACE Heart Failure Meeting held virtually on July 11-14th 2020 and focuses on novel drugs and devices changing the treatment paradigm in Heart Failure management.

Agenda

  • Omecamtiv Mecarbil for Chronic HF - John Teerlink (University of San Francisco, San Francisco, US)
  • Devices for Functional MR beyond Mitraclip - Ralph Stephan von Bardeleben (University of Mainz, Mainz, DE)
  • Devices for Baroreflex Stimulation - Andrew Coats (Monash University, Melbourne, AU)
  • More on New Drugs and Devices on the Horizon - Stefan Anker (Charite University, Berlin, DE)

More from this programme

Part 1

Omecamtiv Mecarbil for Chronic HF

1 session
Omecamtiv Mecarbil for Chronic HF Watch now

Part 2

Devices for Functional MR beyond Mitraclip

1 session
Devices for Functional MR beyond Mitraclip Watch now

Part 3

Devices for Baroreflex Stimulation

1 session
Devices for Baroreflex Stimulation Watch now

Part 4

More on New Drugs and Devices on the Horizon

1 session
More on new drugs and devices on the horizon Watch now

Faculty Biographies

Andrew JS Coats

Andrew JS Coats

Director of the Monash Warwick Alliance and Academic Vice-President

Prof Coats is Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. His research greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He has a vast experience in education and publishing.

Prof Coats attended Melbourne Grammar School and studied at Oxford and Cambridge. He has a higher doctorates from Oxford (DM) and Imperial (DSc.).

Prof Coats was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust. Professor Coats was appointed Dean of Medicine at the University of Sydney in 2002, and subsequently Deputy Vice-Chancellor. Professor Coats was most recently CEO of the Norwich Research Park, the UK's oldest and largest research and innovation park.

Prof Coats research interests are chronic heart failure, hypertension, and organizational…

View full profile